The Long Term Suppression of Experimental Autoimmune Encephalomyelitis by the Opioid Growth Factor and Low Dose Naltrexone

The FASEB Journal
01 April 2011
https://doi.org/10.1096/fasebj.25.1_supplement.677.6 

Intermittent blockade of OGFr and treatment of autoimmune disorders

Exp Biol Med (Maywood)
December 2018
https://pubmed.ncbi.nlm.nih.gov/30541348/

Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study

PLoS One
14 February 2019
https://pubmed.ncbi.nlm.nih.gov/30763385/

Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy

Cureus
11 March 2019
https://pubmed.ncbi.nlm.nih.gov/31123647/

Microglial Phagocytosis of Neurons: Diminishing Neuronal Loss in Traumatic, Infectious, Inflammatory, and Autoimmune CNS Disorders

Front Psychiatr
03 October 2019
https://www.frontiersin.org/articles/10.3389/fpsyt.2019.00712/full

Kris takes LDN for Chronic Lyme pain (Low-dose Naltrexone) from LDN Research Trust on Vimeo.

Low-dose Naltrexone (LDN) & Autoimmunity (LDN) from LDN Research Trust on Vimeo.

The LDN Book Volume 2 & The Goals of the LDN Research Trust (LDN, low-dose Naltrexone) from LDN Research Trust on Vimeo.

A potential anti-inflammatory effect of low-dose naltrexone in fibromyalgia

J Pain
01 April 2015
https://www.jpain.org/article/S1526-5900(15)00362-4/abstract

Treating Lupus Naturally

KMJNow
2021
https://www.kmjnow.com/news/treating-lupus-naturally/

Over 200,000 Americans suffer from the autoimmune disease systemic lupus erythematosus, commonly called lupus, according to a recent study by researchers at NYU Langone Health In New York City. It is the first study to evaluate how widespread this debilitating disease is in the U.S.